New Formula & New Presentation

Swiss Biotechnology Against Aging

Human-Citoplacell 2G

CLINICAL STUDY:

Prove the therapeutic efficacy of complementary therapy with Human Ultracell 2G and Human Citoplacell 2G (according to established dosage guidelines) in the treatment of chronic ageing-related poly-pathological symptoms, during 60 weeks of treatment.

 

 

 


More Information
» Citoplacell 2G
» Clinical Information and Pharmacology
» Mechanisms of Action
» Pharmacokinetics		 » Analysis
» Contraindications
» Side Effects
» Indications & Dosage		 » Clinical Study
» References
» Exclusively For Doctors